Designed for the rapid and precise detection of Methicillin-Resistant Staphylococcus Aureus (MRSA) in healthcare settings to prevent and control infections.
Addresses the significant healthcare challenge of approximately 171,200 healthcare-associated MRSA infections annually in the EU, leading to 5,400 deaths, over 1 million extra hospitalization days, and excess costs of €380 million.
Essential for identifying the estimated 2 to 53 million MRSA carriers worldwide, supporting timely and effective infection control measures.
Helps reduce the average length of hospital stays associated with MRSA infections by enabling faster diagnosis and intervention.
